-
New Jersey's Braeburn Pharma Lands $110M
biospace
January 12, 2018
Braeburn Pharmaceutical(Braeburn) today announced that the Company has completed a $110 million mezzanine round of financing led by Wellington Capital Management.
-
China-based HaploX Biotechnology closes a $32 million Series-A plus financing round
biospectrumasia
January 05, 2018
The company’s technologies include tools for capturing circulating tumor DNA; extracting and amplifying ultra-low concentrations of DNA from liquid samples; performing tagged sequencing; and managing and analyzing the resulting data.
-
Orchard Therapeutics announces $110M Series B Financing
biospectrumasia
December 25, 2017
In conjunction with the financing, Simone Song, senior partner at ORI Capital has been appointed to Orchard's board of directors
-
TARIS Biomedical Announces $25M Series B Financing
biospace
December 22, 2017
TARIS Biomedical, a company developing targeted new therapies for millions of patients suffering from difficult-to-treat bladder diseases, announced today that it has raised $25M in a Series B financing
-
Google-Backed FLX Bio Scores $60M Financing
biospace
December 22, 2017
FLX Bio completed a $60 million Series C financing. New investors included GV (formerly Google Ventures) and undisclosed investors.
-
Orchard Therapeutics Announces $110M Series B Financing to Advance Transformative Gene Therapy Pipel
b3cnewswire
December 21, 2017
Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, today announced the completion of an oversubscribed $110 million (£85 million) Series B financing.
-
Hookipa Biotech raises $60 million in Round C Financing
biospectrumasia
December 13, 2017
All current Hookipa investors, Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures and BioMedPartners participated in the round
-
Lexicon Pharma Secures Up to $200M Non-Dilutive Term Loan Financing
biospace
December 06, 2017
Lexicon Pharmaceuticals has final definitive loan agreements with BioPharma Credit PLC and BioPharma Credit Investments IV Sub LP (an investment fund managed by Pharmakon Advisors, LP)
-
ADC Therapeutics brings in $200 million of financing
pharmafile
October 25, 2017
ADC Therapeutics has won some serious financial support after its latest financing round managed to net the company $200 million.